How an Infusion Provider Renegotiated PPO Contracts and Recovered $180K in 12 Months

A PPO discount is supposed to be a known, contracted number. In practice, most infusion providers never verify that the discount actually applied on a remittance matches the discount they agreed to, and fewer still revisit that number once the contract is signed. Drug costs rise every year. Contracted rates often do not.

At Infusion Billing Services, we recently completed a full payer contract review for an infusion provider whose reimbursement had quietly fallen behind its actual drug costs. This case study explains what a PPO discount actually is, where this provider’s contracts and remittance data were misaligned, and how renegotiating and validating their contracted rates recovered $180,000 in twelve months.

What Is a PPO Discount

A PPO discount is the percentage reduction off billed charges that a provider agrees to accept under a Preferred Provider Organization contract, in exchange for inclusion in that payer’s network and the patient volume that comes with it. The contracted rate that results, whether expressed as a discount off charges, a percentage of Medicare, or a percentage of a drug’s average sales price, is the number that should appear on every remittance tied to that payer.

The PPO discount only works in a provider’s favor when two things hold true. The contracted rate has to reflect current cost realities, particularly for specialty and biologic infusion drugs where acquisition cost moves faster than most contracts are renegotiated. And the discount actually applied on each remittance has to match the contracted rate, not a different rate borrowed from a separate network arrangement.

Neither condition is guaranteed by default. A PPO discount negotiated three years ago on a drug that has since had its acquisition cost rise significantly can turn a previously profitable contract into a losing one without anyone noticing, because the underpayment shows up as a small percentage on each individual claim rather than one visible loss. It only becomes visible when someone aggregates it across a full year of claim volume.

Client Snapshot

Our client was an infusion provider operating three locations, administering biologic and specialty infusion therapies to roughly 300 patients monthly across a payer mix where PPO contracted rates governed the majority of commercial claim volume. Several of their PPO contracts had not been formally renegotiated in more than three years, despite meaningful increases in acquisition cost for several high volume drugs over that period.

We reviewed twelve months of remittance data against the provider’s actual contracted terms before starting the engagement. The review found that the PPO discount applied on a meaningful share of claims did not match what the contracts specified, and that several contracts themselves had never been updated to reflect current drug costs. Neither issue had been caught, because no one at the practice was systematically comparing contracted terms against what payers were actually paying.

Gap 1: Fee Schedules Not Renegotiated Despite Rising Drug Costs

Several PPO contracts had been signed years earlier and never revisited, even as the acquisition cost of the specialty drugs billed under them increased substantially. The PPO discount structure stayed fixed while the underlying cost of delivering care did not.

Problem:

• Contracted rates had not been reviewed since the original PPO discount agreement was signed
• Drug acquisition costs for several high volume infusions had risen well beyond the original terms
• No internal process flagged contracts due for renegotiation

Fix:

• Built a contract review calendar tied to renegotiation windows for every payer agreement
• Compiled current acquisition cost data to support renegotiation on the highest volume drugs
• Renegotiated the most outdated contracts first, prioritized by claim volume

Gap 2: Silent PPO Repricing on Out of Network Claims

A subset of claims for patients without in network coverage were repriced through a separate network rental arrangement the practice had never explicitly agreed to for those payers, applying a PPO discount the practice had not contracted for. This is sometimes called a silent PPO, and it quietly reduces reimbursement on claims that should have been paid at full billed charges or a different negotiated rate.

Problem:

• Out of network claims were repriced using an unrelated rental network arrangement
• The PPO discount applied did not match any contract the practice had actually signed
• No process existed to catch a discount applied without a matching agreement

Fix:

• Cross checked every out of network remittance against the practice’s actual contracted agreements
• Disputed and recovered claims where an unauthorized PPO discount had been applied
• Requested documentation from payers identifying the source of any repricing network used

Gap 3: No Validation of Contracted Rate Against Remittance

Even on claims paid under a legitimate, current contract, the PPO discount actually applied on the remittance sometimes did not match the contracted percentage. These underpayments were small individually and easy to miss without a systematic comparison process.

Problem:

• Remittances were posted without comparing the applied discount to the contracted rate
• Small underpayments accumulated across high claim volume without detection
• No exception report flagged claims paid below the contracted PPO discount rate

Fix:

• Built a rate validation check comparing every remittance against the contracted PPO discount
• Flagged and appealed claims paid below the contracted rate
• Reviewed validation exceptions weekly rather than relying on periodic audits

Gap 4: Multiple PPO Products From the Same Payer Applied Incorrectly

Several payers offered more than one PPO product, each with its own contracted rate, and claims were sometimes processed under the wrong product’s discount. A patient covered under a higher paying PPO product was occasionally reimbursed at the rate of a lower paying one from the same payer.

Problem:

• Multiple PPO products from the same payer were not distinguished at claim submission
• The wrong product’s PPO discount was applied on a subset of claims
• Front end verification did not capture which specific PPO product covered the patient

Fix:

• Added a PPO product identification step to eligibility verification
• Built a reference table matching each payer’s PPO products to their contracted rates
• Flagged claims where the applied PPO discount did not match the verified product

Gap 5: No Recurring Renegotiation Cycle

Contracts renewed automatically year after year with no scheduled review, which meant even legitimate rate increases available through standard renegotiation cycles were being missed entirely.

Problem:

• Contract renewal happened automatically without a renegotiation review
• No one owned tracking renegotiation windows across the full payer portfolio
• Opportunities to improve reimbursement at renewal were consistently missed

Fix:

• Assigned ownership of the full contract renegotiation calendar to a specific role
• Built a standing process to prepare renegotiation cases ahead of each renewal window
• Treated every renewal as a renegotiation opportunity rather than an automatic rollover

How the Recovery Broke Down

Each gap contributed a distinct, separately tracked portion of the total recovery.

Financial Recovery Results

Beyond the dollar recovery, several underlying metrics shifted across the twelve month engagement.

Key Takeaways

• A PPO discount is only accurate when the contracted rate reflects current costs and the applied rate on the remittance matches the contract
• Outdated contracts are a silent loss, since an underpaid PPO discount rarely shows up as a single visible event
• Out of network claims should be checked for repricing through networks the practice never actually agreed to
• Multiple PPO products from the same payer need to be distinguished at verification, not assumed to share one rate
• A recurring renegotiation cycle captures value that an automatic contract rollover never will

Conclusion

Recovering revenue tied to PPO contracts depends on treating the PPO discount as something to actively validate and periodically renegotiate, not a fixed number to accept indefinitely. As this case shows, addressing outdated fee schedules, silent repricing, rate validation, product misapplication, and renegotiation timing together recovered $180,000 in twelve months.

If your infusion practice has not reviewed its PPO contracts recently or validated that remittances match what was actually agreed to, we can help. Infusion Billing Services can audit your current PPO discount arrangements and build a renegotiation strategy around your actual claim volume and drug costs.

Contact Infusion Billing Services today for a complete payer contract and PPO discount review.